Royal Bank of Canada
TTPH

Royal Bank of Canada’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Royal Bank of Canada’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-65
Closed -$4K – 7376
2018
Q3 		$4K Buy
65
+62
+2,067% +$3.96K ﹤0.01% 6381
2018
Q2 		$0 Sell
3
-14
-82% -$988 ﹤0.01% 6926
2018
Q1 		$1K Buy
17
+7
+70% +$614 ﹤0.01% 6257
2017
Q4 		$1K Sell
10
-230
-96% -$29.5K ﹤0.01% 6461
2017
Q3 		$33K Buy
240
+223
+1,312% +$29.8K ﹤0.01% 5668
2017
Q2 		$2K Sell
17
-58
-77% -$8.96K ﹤0.01% 6326
2017
Q1 		$14K Sell
75
-63
-46% -$7.06K ﹤0.01% 5819
2016
Q4 		$11K Buy
+138
New +$10.9K ﹤0.01% 6062
2016
Q1 		– Sell
-8
Closed -$1K – 6805
2015
Q4 		$1K Buy
8
+3
+60% +$599 ﹤0.01% 6533
2015
Q3 		$1K Sell
5
-56
-92% -$41.1K ﹤0.01% 6543
2015
Q2 		$58K Buy
+61
New +$49.9K ﹤0.01% 5152
2014
Q2 		– Sell
-10
Closed -$2K – 6234
2014
Q1 		$2K Buy
+10
New +$2.79K ﹤0.01% 5750
2013
Q4 		– Sell
-12
Closed -$3K – 6257
2013
Q3 		$3K Buy
+12
New +$2.1K ﹤0.01% 5783

Other funds holding TTPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's TTPH Position: Q4 2018 in Review

Royal Bank of Canada sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2018, closing a stake of 65 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in TTPH in Q3 2013 and held it in 13 quarters. The position peaked at $58K in Q2 2015. 86 funds tracked by Wall St. Rank hold TTPH as of Q4 2018.

  • Royal Bank of Canada reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 65 Tetraphase Pharmaceuticals, Inc. shares in Q4 2018, an estimated $4K.
  • Royal Bank of Canada first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 13 quarters.
  • Royal Bank of Canada's Tetraphase Pharmaceuticals, Inc. position peaked at $58K in Q2 2015.
  • 86 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2018.

Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.